Basel Medical
BMGL
10 hedge funds and large institutions have $525K invested in Basel Medical in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, reducing their positions, and 3 closing their positions.
137% more capital invested
Capital invested by funds: $221K → $525K (+$303K)
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
67% more funds holding
Funds holding: 6 → 10 (+4)
0.9% more ownership
Funds ownership: 0.67% → 1.57% (+0.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$194K |
| 2 |
Morgan Stanley
New York
|
+$155K |
| 3 |
MG
Marex Group
London,
|
+$94K |
| 4 |
Vanguard Personalized Indexing Management
Oakland,
California
|
+$46.2K |
| 5 |
VF
Virtu Financial
New York
|
+$36.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$152K |
| 2 |
Barclays
London,
United Kingdom
|
-$2.78K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.57K |
BMGL Hedge Fund Activity: Q3 2025 in Review
10 of the 7,642 institutional investors tracked by Wall St. Rank reported a position in Basel Medical (BMGL) for Q3 2025, worth a combined $525K — up 137% from $221K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BMGL positions and 3 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $194K. The largest seller was HRT Financial, exiting entirely with an estimated $152K sold.
- 10 institutional investors held Basel Medical (BMGL) as of Q3 2025, up from 6 in Q2 2025.
- Funds reported $525K of Basel Medical stock for Q3 2025, up 137% quarter-over-quarter.
- 7 funds opened new Basel Medical positions in Q3 2025 and 3 closed out, a net change of +4 holders.
- The largest Basel Medical buyer in Q3 2025 was Citadel Advisors, an estimated $194K added.
- The largest Basel Medical seller in Q3 2025 was HRT Financial, an estimated $152K sold.
Based on aggregated 13F filings for Q3 2025.